Objective: This study evaluated revascularization strategies for patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease.
Objective: This study sought to compare the 2-year outcomes between bioresorbable vascular scaffold (BVS) and everolimus-eluting metallic drug-eluting stent (EES).
Objectives: The study sought to evaluate the efficacy and safety of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) (Abbott Vascular, Abbott Park, Illinois) in patients with diabetes mellitus.
Objectives: This study sought to describe the results of transcatheter tricuspid valve-in-ring (TVIR) implantation for treatment of tricuspid regurgitation (TR).
Objectives: The aims of this study were to assess the impact of atrial fibrillation (AF) on outcome in transfemoral aortic valve replacement (TAVR) and to evaluate the safety and efficacy of apixaban compared with a vitamin K antagonist (VKA) in patients with AF after TAVR.
A 66-year-old African-American woman with no significant medical history presented with a 2-day history of worsening exertional dyspnea with minimal activity. Pulmonary embolus (PE) was suspected on the basis of clinical presentation and elevated D-dimer levels in absence of other clear explanation for her symptoms. Computed tomography of the chest revealed extensive, acute bilateral pulmonary embolus with significant clot burden in the right main pulmonary artery (PA). There was evidence of right heart strain with right ventricular (RV) dilation (elevated troponin [0.39 ng/ml] and brain natriuretic peptide [187 pg/ml]; right ventricle/left ventricle ratio 1.17 on computed tomography). Transthoracic echocardiography confirmed moderate RV dilation and systolic dysfunction. The patient’s estimated RV systolic pressure was 71 mm Hg. She was hemodynamically stable at admission, with normal blood pressure and heart rate and oxygen saturation >90% on room air. Given her hemodynamic stability and on the basis of the patient’s own preference, she was started on intravenous heparin and conservative management.
A 33-year-old man underwent routine percutaneous coronary intervention for a left anterior descending artery stenosis (fractional flow reserve 0.79) (Figure 1A). After stepwise pre-dilation up to 3.0 mm, a 3.5 × 28-mm Novolimus-eluting bioresorbable vascular scaffold (NE-BVS) (Elixir Medical, Sunnyvale, California) was implanted followed by post-dilation up to a 4.0-mm noncompliant balloon due to initial angiographically insufficient stent deployment (Figure 1B). Six months after implantation, routine angiography revealed a large aneurysm at the site of prior BVS implantation (Figure 1C, Online Video 1). Given the rapidness of development with a subsequent high danger of rupture, the decision was made for percutaneous treatment.
A 70-year-old man with persistent atrial fibrillation was referred for percutaneous left atrial appendage occlusion. Because of a high cardioembolic stroke risk (with a CHA2DS2-VASc score of 3 points) and given his previous history of gastric bleeding during anticoagulation treatment, we decided to perform left atrial appendage closure. We successfully deployed a 28-mm AMPLATZER Cardiac Plug (ACP) (St. Jude Medical, Minneapolis, Minnesota) device
A 66-year-old man with previous coronary artery bypass graft surgery was referred to cardiac catheterization due to a non–ST-segment elevation acute myocardial infarction. On arrival he was hemodynamically stable and complaining of mild chest discomfort. Coronary angiography showed a patent saphenous vein graft (SVG) to distal right coronary artery with severe stenosis in the proximal and midsegment (Figure 1A). The choice for percutaneous coronary intervention was made.
Objectives: The purpose of this study was to evaluate long-term clinical impact of routine follow-up coronary angiography (FUCAG) after percutaneous coronary intervention (PCI) in daily clinical practice in Japan.
Objectives: This randomized trial tested whether early loading with prasugrel can provide sufficient platelet inhibition even when given at the start of a 2-h infusion of cangrelor.
Objectives: The aim of this study was to investigate the efficacy and safety of the hybrid ultrathin-strut sirolimus-eluting stent (SES) with biodegradable polymer compared with the thin-strut everolimus-eluting stent (EES) with durable polymer in successfully recanalized chronic total occlusions (CTOs).
Objectives: This study sought to assess the safety and effectiveness of the drug-filled stent (DFS) (Medtronic, Santa Rosa, California) in the treatment of patients with coronary artery disease.
Objectives: The aim of this study was to assess the safety and effectiveness of the COBRA Polyzene-F NanoCoated Coronary Stent System (CeloNova Biosciences, San Antonio, Texas) for the treatment of de novo coronary artery lesions.
Objectives: This study sought to explore the impact of balloon post-dilation (BPD) on outcomes in the CoreValve US Clinical Trials.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos